(Press Release) MabGenesis announces collaboration with MSD Animal Health to discover and develop novel monoclonal antibodies for use in companion animals

MabGenesis and MSD Animal Health, a global leader in animal health, today announced that they have entered into a collaboration to discover and develop novel monoclonal antibodies for potential companion animal therapeutic treatments. MSD Animal Health is a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK).

Please see the press release here.